These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 16885378

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccines.
    Singh R, Paterson Y.
    Cancer Immunol Immunother; 2007 Jun; 56(6):927-38. PubMed ID: 17131121
    [Abstract] [Full Text] [Related]

  • 3. Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.
    NoeDominguez-Romero A, Zamora-Alvarado R, Servín-Blanco R, Pérez-Hernández EG, Castrillon-Rivera LE, Munguia ME, Acero G, Govezensky T, Gevorkian G, Manoutcharian K.
    Hum Vaccin Immunother; 2014 Jun; 10(11):3201-13. PubMed ID: 25483665
    [Abstract] [Full Text] [Related]

  • 4. HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice.
    Vertuani S, Triulzi C, Roos AK, Charo J, Norell H, Lemonnier F, Pisa P, Seliger B, Kiessling R.
    Cancer Immunol Immunother; 2009 May; 58(5):653-64. PubMed ID: 18820911
    [Abstract] [Full Text] [Related]

  • 5. Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy.
    Lekka E, Gritzapis AD, Perez SA, Tsavaris N, Missitzis I, Mamalaki A, Papamichail M, Baxevanis CN.
    Cancer Immunol Immunother; 2010 May; 59(5):715-27. PubMed ID: 19904532
    [Abstract] [Full Text] [Related]

  • 6. Ii-Key/HER-2/neu(776-790) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors.
    Sotiriadou NN, Kallinteris NL, Gritzapis AD, Voutsas IF, Papamichail M, von Hofe E, Humphreys RE, Pavlis T, Perez SA, Baxevanis CN.
    Cancer Immunol Immunother; 2007 May; 56(5):601-13. PubMed ID: 16960693
    [Abstract] [Full Text] [Related]

  • 7. An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.
    Seavey MM, Maciag PC, Al-Rawi N, Sewell D, Paterson Y.
    J Immunol; 2009 May 01; 182(9):5537-46. PubMed ID: 19380802
    [Abstract] [Full Text] [Related]

  • 8. T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C.
    Flickinger JC, Singh J, Yarman Y, Carlson RD, Barton JR, Waldman SA, Snook AE.
    Front Immunol; 2022 May 01; 13():855759. PubMed ID: 35355987
    [Abstract] [Full Text] [Related]

  • 9. Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity.
    Jacob JB, Kong YC, Nalbantoglu I, Snower DP, Wei WZ.
    J Immunol; 2009 May 01; 182(9):5873-81. PubMed ID: 19380836
    [Abstract] [Full Text] [Related]

  • 10. Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice.
    Esserman LJ, Lopez T, Montes R, Bald LN, Fendly BM, Campbell MJ.
    Cancer Immunol Immunother; 1999 Feb 01; 47(6):337-42. PubMed ID: 10203064
    [Abstract] [Full Text] [Related]

  • 11. Multi-level Strategy for Identifying Proteasome-Catalyzed Spliced Epitopes Targeted by CD8+ T Cells during Bacterial Infection.
    Platteel ACM, Liepe J, Textoris-Taube K, Keller C, Henklein P, Schalkwijk HH, Cardoso R, Kloetzel PM, Mishto M, Sijts AJAM.
    Cell Rep; 2017 Aug 01; 20(5):1242-1253. PubMed ID: 28768206
    [Abstract] [Full Text] [Related]

  • 12. Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes.
    Sarén A, Pascolo S, Stevanovic S, Dumrese T, Puolakkainen M, Sarvas M, Rammensee HG, Vuola JM.
    Infect Immun; 2002 Jul 01; 70(7):3336-43. PubMed ID: 12065471
    [Abstract] [Full Text] [Related]

  • 13. Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer.
    Hannan R, Zhang H, Wallecha A, Singh R, Liu L, Cohen P, Alfieri A, Rothman J, Guha C.
    Cancer Immunol Immunother; 2012 Dec 01; 61(12):2227-38. PubMed ID: 22644735
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination.
    Rad-Malekshahi M, Fransen MF, Krawczyk M, Mansourian M, Bourajjaj M, Chen J, Ossendorp F, Hennink WE, Mastrobattista E, Amidi M.
    Mol Pharm; 2017 May 01; 14(5):1482-1493. PubMed ID: 28088862
    [Abstract] [Full Text] [Related]

  • 16. Identification of a dominant murine T-cell epitope in recombinant protein P29 from Echinococcus granulosus.
    Lv Y, Zhu Y, Chang L, Yang J, Zhao Y, Zhao J, Wang Y, Zhu M, Wu C, Zhao W.
    Acta Biochim Biophys Sin (Shanghai); 2022 Apr 25; 54(4):482-493. PubMed ID: 35607954
    [Abstract] [Full Text] [Related]

  • 17. A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control.
    Xu Z, Chokkalingam N, Tello-Ruiz E, Wise MC, Bah MA, Walker S, Tursi NJ, Fisher PD, Schultheis K, Broderick KE, Humeau L, Kulp DW, Weiner DB.
    Cancer Immunol Res; 2020 Nov 25; 8(11):1354-1364. PubMed ID: 32913042
    [Abstract] [Full Text] [Related]

  • 18. Immunopeptidomics Mapping of Listeria monocytogenes T Cell Epitopes in Mice.
    Gul A, Pewe LL, Willems P, Mayer R, Thery F, Asselman C, Aernout I, Verbeke R, Eggermont D, Van Moortel L, Upton E, Zhang Y, Boucher K, Miret-Casals L, Demol H, De Smedt SC, Lentacker I, Radoshevich L, Harty JT, Impens F.
    Mol Cell Proteomics; 2024 Aug 13; 23(9):100829. PubMed ID: 39147027
    [Abstract] [Full Text] [Related]

  • 19. Multiplex Screening Assay for Identifying Cytotoxic CD8+ T Cell Epitopes.
    Poh CM, Zheng J, Channappanavar R, Chang ZW, Nguyen THO, Rénia L, Kedzierska K, Perlman S, Poon LLM.
    Front Immunol; 2020 Aug 13; 11():400. PubMed ID: 32218786
    [Abstract] [Full Text] [Related]

  • 20. Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope.
    Martinenaite E, Ahmad SM, Bendtsen SK, Jørgensen MA, Weis-Banke SE, Svane IM, Andersen MH.
    Cancer Immunol Immunother; 2019 Nov 13; 68(11):1901-1907. PubMed ID: 31690955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.